TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A registered dietitian says zinc lozenges started soon after cold symptoms begin may shorten a cold, with a 2024 Cochrane review estimating a possible reduction of about two days. The evidence is low certainty, does not show a convincing reduction in overall symptom severity, and studied doses can exceed recommended daily limits.
A 2024 Cochrane review found that zinc may shorten a common cold by about two days, according to registered dietitian Johannah Katz, but the evidence was rated low certainty and does not establish zinc as a reliable treatment. A Fit&Well report says the possible benefit appears strongest for lozenges started within 24 hours of the first symptoms, while warning that the doses studied can exceed recommended limits.
Katz told Fit&Well that zinc may be more useful as a short-term measure after symptoms begin than as a supplement taken routinely to prevent illness. The Cochrane review found a possible reduction in how long a cold lasts, but researchers had varied substantially in dose, formulation and study design. The review did not find convincing evidence that zinc meaningfully reduces overall symptom severity.
The report says trials reporting benefits commonly used roughly 75 to 90 milligrams of elemental zinc per day, often for less than two weeks. Elemental zinc is the amount of the mineral itself, rather than the combined weight of a zinc compound. Katz said lozenges have better supporting evidence than swallowed tablets; both zinc acetate and zinc gluconate lozenges have shown benefit, with no significant difference between them in one meta-analysis cited in the report.
Those amounts require caution. Katz noted that the US adult tolerable upper intake level is 40 milligrams a day from food and supplements, while NHS guidance advises adults not to take more than 25 milligrams of zinc supplements daily unless a doctor recommends it. Reported side effects include nausea, stomach upset and a metallic taste. Long-term high-dose use can interfere with copper absorption, and zinc may interact with certain antibiotics and penicillamine.
The Possible Benefit Comes With Limits
A cold has no established cure, so even a modest reduction in its duration could matter to people seeking symptom relief. But the reported estimate should not be treated as a guaranteed result: the Cochrane review’s low-certainty finding means the true effect could differ, and it found no convincing reduction in overall symptom severity.
The practical issue is that the doses associated with possible benefit are higher than public-health limits for routine intake. That makes formulation, timing and dose relevant, rather than supporting broad advice to take zinc whenever cold season arrives. Katz’s account points to lozenges used early as the more promising approach, but readers should weigh that possibility against side effects, interactions and national dosage guidance.
There is also a safety distinction between products taken by mouth and products used in the nose. Katz advised against intranasal zinc sprays or gels, which the report says have been linked with potentially permanent loss of smell. The potential benefit of a lozenge does not justify assuming that every zinc product has the same evidence or risk profile.
As an affiliate, we earn on qualifying purchases.
What the Zinc Research Examined
Zinc is a mineral needed for normal immune function. The Fit&Well report describes researchers’ proposed explanations for a possible effect: zinc may make it harder for cold viruses to spread or reproduce, and lozenges may release zinc locally around the mouth and throat. These explanations remain possible mechanisms, not confirmed findings.
The report also refers to a meta-analysis of seven trials that found zinc lozenges containing more than 75 milligrams of zinc shortened colds by an average of 33% compared with placebo. That result is separate from the Cochrane review’s estimate of about two days. The supplied report does not provide the meta-analysis’s publication date, the full trial details or the basis needed to compare the two estimates directly.
For prevention, the picture is less encouraging. Katz said the latest Cochrane review found preventive zinc supplementation may have little or no effect on the chance of developing a cold. The report therefore frames possible use as short-term and symptom-led, not as routine protection.
As an affiliate, we earn on qualifying purchases.
Dose, Timing and Effect Remain Unsettled
The evidence does not establish exactly how much zinc an individual should take, which product will work best, or how consistently people can expect a shorter cold. Studies differed in dose, formulation and design, and the Cochrane review rated its evidence low certainty. The report does not provide enough detail to assess the participant numbers or the methods of each cited trial.
It is also unclear how the seven-trial meta-analysis’s 33% average reduction relates to the Cochrane review’s estimate of about two days. The source material does not give the meta-analysis’s date or the baseline duration of colds in those trials, so the percentage cannot be converted into a number of days from the information provided.
The proposed antiviral action of zinc has not been confirmed, and a possible reduction in duration is not the same as preventing infection or reliably easing symptoms. Individual safety can also depend on other supplements, medicines and health circumstances. The report advises people taking medication to check for interactions, but it does not detail risks for every group.
As an affiliate, we earn on qualifying purchases.
Check Guidance Before High Doses
The report identifies no new trial or regulatory decision as the next milestone. For now, the evidence cited remains the 2024 Cochrane review and the separate meta-analysis described in the article; further research would need to clarify which doses and formulations offer a reproducible benefit and how they compare with safety limits.
Anyone considering zinc for a cold should follow local health guidance and speak with a pharmacist or healthcare professional before using high doses, particularly if they take medication or have a health condition. The report advises avoiding nasal zinc products because of the possible risk to smell. Readers should not treat the available findings as a reason to exceed recommended limits or as a substitute for professional advice.
As an affiliate, we earn on qualifying purchases.
Key Questions
Can zinc shorten a cold?
A 2024 Cochrane review found zinc may shorten a cold by about two days, but the evidence was rated low certainty. The finding is not a guarantee for any individual.
Which zinc products have more evidence?
The report says evidence is better for zinc lozenges than for swallowed tablets. Zinc acetate and zinc gluconate lozenges have both shown benefit in studies cited by dietitian Johannah Katz.
When would zinc need to be started?
Katz said the strongest evidence supports starting zinc within 24 hours of the first symptoms. The source does not establish that this timing will help everyone.
Are the studied doses safe to take without advice?
Not necessarily. Trials commonly used about 75 to 90 milligrams of elemental zinc daily, above the US adult upper intake level of 40 milligrams and the NHS supplement guidance of 25 milligrams unless advised by a doctor. Ask a pharmacist or healthcare professional before taking high doses.
Should zinc be used to prevent colds?
The report says preventive zinc may have little or no effect on the likelihood of developing a cold, according to the latest Cochrane review cited by Katz. The possible benefit appears stronger when zinc is used as a short-term measure after symptoms begin.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
